Market Snapshot

BSE Sensex: 77100.47 0.14%
BSE 500: 36133.32 -0.05%
BSE 200: 11237.3 0.04%
BSE 100: 25618.46 0.14%
BSE BANKEX: 65599.62 0.03%
BSE IT: 26650.91 -0.88%
Nifty 50: 24056 0.14%
Nifty 500: 23113.7 -0.05%
Nifty 200: 13891.25 0.01%
Nifty 100: 25114.1 0.15%
Nifty Midcap 100: 61795.5 -0.55%
Nifty Small 100: 18790.35 -0.47%
Nifty IT: 27330.85 -0.86%
Nifty PSU Bank: 8636.1 0.09%

News:

Bluspring Enterprises bags O&M...
Godrej Industries invests Rs 3...
Transrail Lightning secures Rs...
CARE Ratings reaffirms ratings...
Meta Infotech bags Rs 5-cr sof...

Medicamen Biotech Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

25 Jun 2026 | 03:59 PM

228.40

-1.25 (-0.54%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-44.94%

Return (1Y)

Underperformed BSE Sensex by 38.1%
More Volatile

2.7%

Standard Deviation (1Y)

Higher than BSE Sensex by 1.86%
Not so consistent

4/12

Months

underperformed BSE Sensex
AxisDirect View

No View

52 Week High-Low

454

218

News & Announcements

Board of Medicamen Biotech recommends final dividend
30 days ago

Board of Medicamen Biotech recommends final dividend

28 - May - 2026 12:00 | 30 days ago

Medicamen Biotech announced that the Board of Directors of the Company at its meeting held on 27 May 2026, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.

Medicamen Biotech consolidated net profit rises 59.50% in the March 2026 quarter

31 days ago

Medicamen Biotech to announce Quarterly Result
36 days ago

Medicamen Biotech to announce Quarterly Result

22 - May - 2026 12:00 | 36 days ago

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 27 May 2026.
Medicamen Biotech consolidated net profit declines 36.89% in the December 2025 quarter
133 days ago

Medicamen Biotech consolidated net profit declines 36.89% in the December 2025 quarter

14 - Feb - 2026 12:00 | 133 days ago

Net profit of Medicamen Biotech declined 36.89% to Rs 2.19 crore in the quarter ended December 2025 as against Rs 3.47 crore during the previous quarter ended December 2024. Sales rose 3.92% to Rs 46.91 crore in the quarter ended December 2025 as against Rs 45.14 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 46.91 45.14 4

OPM % 9.34 14.86 -

PBDT 3.94 6.09 -35

PBT 2.11 3.88 -46

NP 2.19 3.47 -37

Powered by Capital Market - Live News

Price vs Volume

1D
5D
1M
3M
1Y
3Y
5Y
MAX

Stock Trivia

Medicamen Biotech Ltd is trading very close to its All time Low
Medicamen Biotech Ltd is trading very close to its 52 Week Low
FII shareholding in Medicamen Biotech Ltd has increased by 359.62% since past 3 Months
FII shareholding in Medicamen Biotech Ltd has decreased by -14.94% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

×

Online trading for clients based in USA and Canada is restricted. You can continue placing orders through mapped dealers offline

OK

vV5.0.0.6-60